ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,120,465 | +10.3% | 15,570 | -0.9% | 0.53% | +0.8% |
| Q3 2023 | $1,922,250 | -3.8% | 15,719 | -0.3% | 0.53% | +1.0% |
| Q2 2023 | $1,997,472 | -4.2% | 15,768 | -2.8% | 0.52% | -10.8% |
| Q1 2023 | $2,086,074 | -7.4% | 16,221 | -5.4% | 0.58% | -5.7% |
| Q4 2022 | $2,251,831 | +10.9% | 17,151 | -1.3% | 0.62% | +7.8% |
| Q3 2022 | $2,031,000 | +2.4% | 17,370 | +3.0% | 0.57% | +10.6% |
| Q2 2022 | $1,984,000 | -10.2% | 16,870 | -0.4% | 0.52% | +10.0% |
| Q1 2022 | $2,209,000 | -15.0% | 16,935 | -0.6% | 0.47% | -12.3% |
| Q4 2021 | $2,599,000 | -6.2% | 17,035 | -0.6% | 0.54% | -14.3% |
| Q3 2021 | $2,771,000 | -8.2% | 17,140 | -7.1% | 0.63% | -9.2% |
| Q2 2021 | $3,020,000 | +8.3% | 18,457 | -0.9% | 0.69% | -0.4% |
| Q1 2021 | $2,788,000 | -41.0% | 18,634 | -40.2% | 0.70% | -35.3% |
| Q4 2020 | $4,722,000 | +9.5% | 31,144 | -2.3% | 1.07% | +0.3% |
| Q3 2020 | $4,314,000 | -1.3% | 31,884 | -0.5% | 1.07% | -8.5% |
| Q2 2020 | $4,369,000 | +47.8% | 32,034 | +16.7% | 1.17% | +33.1% |
| Q1 2020 | $2,957,000 | -8.4% | 27,454 | +2.4% | 0.88% | +21.2% |
| Q4 2019 | $3,229,000 | +19.8% | 26,804 | -1.1% | 0.73% | +16.0% |
| Q3 2019 | $2,695,000 | -12.2% | 27,104 | -2.2% | 0.63% | -9.8% |
| Q2 2019 | $3,068,000 | -0.1% | 27,713 | -1.6% | 0.69% | -0.7% |
| Q1 2019 | $3,070,000 | +8.4% | 28,173 | -2.4% | 0.70% | -5.4% |
| Q4 2018 | $2,831,000 | -29.4% | 28,874 | -11.3% | 0.74% | -15.6% |
| Q3 2018 | $4,010,000 | +10.7% | 32,539 | -0.1% | 0.88% | +5.3% |
| Q2 2018 | $3,621,000 | +2.5% | 32,569 | -0.3% | 0.83% | +1.6% |
| Q1 2018 | $3,533,000 | -0.5% | 32,678 | -0.5% | 0.82% | -0.5% |
| Q4 2017 | $3,550,000 | -10.7% | 32,828 | +175.5% | 0.82% | -14.2% |
| Q3 2017 | $3,975,000 | +9.0% | 11,916 | +0.2% | 0.96% | +5.6% |
| Q2 2017 | $3,647,000 | -3.3% | 11,891 | -7.5% | 0.91% | -4.1% |
| Q1 2017 | $3,772,000 | +14.5% | 12,862 | +3.6% | 0.95% | +6.4% |
| Q4 2016 | $3,295,000 | -12.3% | 12,418 | -4.3% | 0.89% | -16.4% |
| Q3 2016 | $3,756,000 | +24.5% | 12,978 | +10.7% | 1.06% | +20.5% |
| Q2 2016 | $3,017,000 | +164.4% | 11,727 | +168.0% | 0.88% | +157.4% |
| Q1 2016 | $1,141,000 | -27.4% | 4,375 | -5.8% | 0.34% | -24.4% |
| Q4 2015 | $1,572,000 | +17.9% | 4,645 | +5.7% | 0.45% | +23.4% |
| Q3 2015 | $1,333,000 | -13.3% | 4,395 | +5.5% | 0.37% | +1.4% |
| Q2 2015 | $1,537,000 | +31.0% | 4,165 | +22.0% | 0.36% | +31.0% |
| Q1 2015 | $1,173,000 | +13.2% | 3,415 | 0.0% | 0.28% | +12.6% |
| Q4 2014 | $1,036,000 | +15.6% | 3,415 | +4.3% | 0.25% | +16.0% |
| Q3 2014 | $896,000 | +8.7% | 3,275 | +2.2% | 0.21% | +9.8% |
| Q2 2014 | $824,000 | -5.5% | 3,205 | -13.1% | 0.19% | -8.1% |
| Q1 2014 | $872,000 | +7.3% | 3,690 | +3.1% | 0.21% | -1.4% |
| Q4 2013 | $813,000 | +16.1% | 3,580 | +7.2% | 0.21% | +8.1% |
| Q3 2013 | $700,000 | +20.5% | 3,340 | 0.0% | 0.20% | +18.0% |
| Q2 2013 | $581,000 | – | 3,340 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |